Concepts (155)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Trypanosoma cruzi | 16 | 2023 | 149 | 4.790 |
Why?
|
| Chagas Disease | 11 | 2023 | 98 | 3.210 |
Why?
|
| Thrombospondin 1 | 4 | 2022 | 23 | 2.030 |
Why?
|
| RNA, Small Interfering | 3 | 2021 | 409 | 1.520 |
Why?
|
| Protozoan Proteins | 6 | 2020 | 182 | 1.300 |
Why?
|
| Dietary Fats, Unsaturated | 2 | 2023 | 9 | 1.070 |
Why?
|
| Premature Birth | 2 | 2023 | 75 | 0.970 |
Why?
|
| Active Transport, Cell Nucleus | 2 | 2022 | 59 | 0.940 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2022 | 22 | 0.840 |
Why?
|
| beta Catenin | 1 | 2022 | 48 | 0.800 |
Why?
|
| Endothelial Cells | 2 | 2022 | 308 | 0.740 |
Why?
|
| Myoblasts | 1 | 2020 | 27 | 0.740 |
Why?
|
| Myocytes, Cardiac | 2 | 2020 | 166 | 0.630 |
Why?
|
| Myocardium | 1 | 2020 | 235 | 0.630 |
Why?
|
| Epithelial Cells | 3 | 2018 | 384 | 0.620 |
Why?
|
| Colon | 1 | 2018 | 103 | 0.610 |
Why?
|
| Phosphoproteins | 1 | 2018 | 163 | 0.590 |
Why?
|
| Proteome | 1 | 2018 | 144 | 0.590 |
Why?
|
| Chagas Cardiomyopathy | 1 | 2016 | 8 | 0.550 |
Why?
|
| Gene Regulatory Networks | 2 | 2016 | 120 | 0.470 |
Why?
|
| Animals | 19 | 2023 | 15081 | 0.450 |
Why?
|
| Calreticulin | 1 | 2012 | 7 | 0.430 |
Why?
|
| Cell Membrane | 3 | 2013 | 381 | 0.400 |
Why?
|
| Mice | 9 | 2023 | 5913 | 0.400 |
Why?
|
| RNA Interference | 3 | 2010 | 243 | 0.400 |
Why?
|
| Heart | 2 | 2023 | 180 | 0.370 |
Why?
|
| Coronary Vessels | 1 | 2010 | 85 | 0.350 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2010 | 86 | 0.340 |
Why?
|
| Onchocerciasis | 3 | 2007 | 6 | 0.300 |
Why?
|
| Humans | 21 | 2023 | 37093 | 0.300 |
Why?
|
| Laminin | 1 | 2006 | 61 | 0.270 |
Why?
|
| Fish Oils | 2 | 2023 | 12 | 0.270 |
Why?
|
| Gene Silencing | 1 | 2006 | 151 | 0.260 |
Why?
|
| Rats | 4 | 2022 | 3483 | 0.250 |
Why?
|
| Helminth Proteins | 2 | 2002 | 25 | 0.240 |
Why?
|
| Oxadiazoles | 2 | 2015 | 15 | 0.240 |
Why?
|
| Onchocerca | 2 | 2002 | 4 | 0.240 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 2023 | 22 | 0.220 |
Why?
|
| Gene Expression Regulation | 2 | 2021 | 1015 | 0.220 |
Why?
|
| Pneumonia | 1 | 2023 | 54 | 0.210 |
Why?
|
| Endothelium | 1 | 2022 | 31 | 0.200 |
Why?
|
| Fibroblasts | 1 | 2023 | 272 | 0.190 |
Why?
|
| Animals, Newborn | 1 | 2022 | 343 | 0.190 |
Why?
|
| alpha-Defensins | 2 | 2013 | 17 | 0.190 |
Why?
|
| Communicable Diseases | 1 | 2021 | 45 | 0.180 |
Why?
|
| Gene Knockout Techniques | 1 | 2020 | 51 | 0.180 |
Why?
|
| Gene Expression Profiling | 2 | 2016 | 626 | 0.170 |
Why?
|
| Trans-Activators | 1 | 2020 | 174 | 0.170 |
Why?
|
| Diet | 2 | 2023 | 801 | 0.170 |
Why?
|
| Cloning, Molecular | 2 | 2012 | 325 | 0.170 |
Why?
|
| Antigens, Helminth | 3 | 2007 | 34 | 0.160 |
Why?
|
| Mice, Knockout | 1 | 2022 | 933 | 0.160 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2020 | 190 | 0.160 |
Why?
|
| Cell Cycle Proteins | 1 | 2020 | 229 | 0.160 |
Why?
|
| DNA-Binding Proteins | 1 | 2020 | 539 | 0.140 |
Why?
|
| Proteomics | 1 | 2018 | 325 | 0.140 |
Why?
|
| Imidazoles | 2 | 2015 | 126 | 0.140 |
Why?
|
| Cells, Cultured | 2 | 2018 | 1518 | 0.130 |
Why?
|
| Leishmaniasis, Visceral | 1 | 2015 | 7 | 0.130 |
Why?
|
| Fibrosis | 1 | 2016 | 159 | 0.130 |
Why?
|
| Antiprotozoal Agents | 1 | 2015 | 30 | 0.130 |
Why?
|
| Models, Biological | 1 | 2018 | 677 | 0.130 |
Why?
|
| Variant Surface Glycoproteins, Trypanosoma | 1 | 2014 | 8 | 0.120 |
Why?
|
| Adenoviridae | 1 | 2014 | 62 | 0.120 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2015 | 92 | 0.120 |
Why?
|
| Benzamides | 1 | 2015 | 78 | 0.120 |
Why?
|
| Cardiovascular Diseases | 1 | 2021 | 664 | 0.120 |
Why?
|
| Genetic Vectors | 1 | 2014 | 158 | 0.120 |
Why?
|
| Capsid Proteins | 1 | 2014 | 67 | 0.120 |
Why?
|
| Onchocerca volvulus | 2 | 2007 | 5 | 0.120 |
Why?
|
| Flagella | 1 | 2013 | 29 | 0.110 |
Why?
|
| Locomotion | 1 | 2013 | 97 | 0.110 |
Why?
|
| Life Cycle Stages | 1 | 2012 | 29 | 0.110 |
Why?
|
| Immunoprecipitation | 1 | 2012 | 131 | 0.100 |
Why?
|
| Staining and Labeling | 1 | 2012 | 105 | 0.100 |
Why?
|
| Cytokines | 1 | 2016 | 602 | 0.100 |
Why?
|
| Female | 8 | 2023 | 20969 | 0.100 |
Why?
|
| Signal Transduction | 1 | 2020 | 1908 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 2 | 2014 | 1609 | 0.100 |
Why?
|
| Neoplasms | 1 | 2021 | 1103 | 0.090 |
Why?
|
| Enzyme Inhibitors | 1 | 2013 | 433 | 0.090 |
Why?
|
| Casein Kinase II | 2 | 2008 | 15 | 0.090 |
Why?
|
| Neuraminidase | 2 | 2008 | 9 | 0.090 |
Why?
|
| Protein Binding | 1 | 2012 | 972 | 0.080 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2010 | 306 | 0.080 |
Why?
|
| Ligands | 1 | 2010 | 349 | 0.080 |
Why?
|
| Male | 5 | 2023 | 20025 | 0.080 |
Why?
|
| Disease Models, Animal | 3 | 2023 | 1371 | 0.080 |
Why?
|
| Up-Regulation | 1 | 2010 | 513 | 0.070 |
Why?
|
| DNA Fragmentation | 1 | 2007 | 92 | 0.070 |
Why?
|
| Transcription, Genetic | 1 | 2010 | 578 | 0.070 |
Why?
|
| Myoblasts, Cardiac | 1 | 2006 | 4 | 0.070 |
Why?
|
| Serologic Tests | 2 | 2007 | 43 | 0.070 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2007 | 448 | 0.070 |
Why?
|
| Antigens, Protozoan | 1 | 2006 | 72 | 0.070 |
Why?
|
| Immunoglobulin G | 2 | 2007 | 237 | 0.060 |
Why?
|
| Recombinant Proteins | 2 | 2007 | 515 | 0.060 |
Why?
|
| Sensitivity and Specificity | 2 | 2007 | 562 | 0.060 |
Why?
|
| Antibodies, Helminth | 2 | 2002 | 23 | 0.060 |
Why?
|
| Fathers | 1 | 2023 | 33 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 2 | 2002 | 448 | 0.050 |
Why?
|
| Membrane Proteins | 1 | 2006 | 517 | 0.050 |
Why?
|
| Mice, Inbred BALB C | 2 | 2015 | 661 | 0.050 |
Why?
|
| Base Sequence | 2 | 2002 | 997 | 0.050 |
Why?
|
| Geography | 1 | 2002 | 96 | 0.050 |
Why?
|
| DNA Primers | 1 | 2002 | 286 | 0.050 |
Why?
|
| Protein Multimerization | 1 | 2002 | 103 | 0.050 |
Why?
|
| Infant, Newborn | 1 | 2023 | 894 | 0.040 |
Why?
|
| Lung | 1 | 2023 | 446 | 0.040 |
Why?
|
| Infant | 1 | 2023 | 1046 | 0.040 |
Why?
|
| Pregnancy | 1 | 2023 | 1549 | 0.040 |
Why?
|
| B-Lymphocytes | 1 | 1997 | 185 | 0.040 |
Why?
|
| HLA-DP Antigens | 1 | 1996 | 1 | 0.030 |
Why?
|
| Biotransformation | 1 | 2015 | 67 | 0.030 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2015 | 83 | 0.030 |
Why?
|
| Microsomes, Liver | 1 | 2015 | 70 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 1997 | 357 | 0.030 |
Why?
|
| Child | 1 | 2023 | 3131 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 2015 | 207 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2015 | 409 | 0.030 |
Why?
|
| HCT116 Cells | 1 | 2013 | 35 | 0.030 |
Why?
|
| Molecular Sequence Data | 3 | 2006 | 1568 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2015 | 492 | 0.030 |
Why?
|
| Africa | 2 | 2007 | 76 | 0.030 |
Why?
|
| Molecular Weight | 2 | 2006 | 167 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2013 | 224 | 0.030 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 1992 | 24 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2013 | 325 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 1992 | 290 | 0.020 |
Why?
|
| Amino Acid Sequence | 2 | 2006 | 1180 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2013 | 484 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2013 | 1369 | 0.020 |
Why?
|
| Host-Parasite Interactions | 1 | 2008 | 42 | 0.020 |
Why?
|
| Serine Endopeptidases | 1 | 2008 | 38 | 0.020 |
Why?
|
| Cysteine Endopeptidases | 1 | 2008 | 59 | 0.020 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2007 | 34 | 0.020 |
Why?
|
| Vacuoles | 1 | 2007 | 25 | 0.020 |
Why?
|
| Glycoproteins | 1 | 2008 | 106 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2007 | 225 | 0.020 |
Why?
|
| Age Distribution | 1 | 2007 | 225 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2007 | 146 | 0.020 |
Why?
|
| Cytoplasm | 1 | 2007 | 143 | 0.020 |
Why?
|
| Hela Cells | 1 | 2007 | 366 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2006 | 212 | 0.020 |
Why?
|
| Virulence Factors | 1 | 2006 | 113 | 0.020 |
Why?
|
| Adolescent | 3 | 2007 | 5363 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2007 | 1130 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2006 | 928 | 0.010 |
Why?
|
| Middle Aged | 3 | 2007 | 10129 | 0.010 |
Why?
|
| Adult | 3 | 2007 | 11712 | 0.010 |
Why?
|
| Immunodominant Epitopes | 1 | 1997 | 27 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1997 | 295 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 1997 | 236 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 1992 | 212 | 0.010 |
Why?
|
| Aged | 1 | 1997 | 6741 | 0.000 |
Why?
|